MarketPeel
Insider Trading Intelligence
BC

Brian Cogley

COEP
CHIEF FINANCIAL OFFICER · COEPTIS THERAPEUTICS HOLDINGS, INC. · CIK 0002008384
FILING MIX · LIFETIME100%/0%
BUYS
4
SELLS
0
TOTAL VALUE
$109.0K
COMPANIES
1
ACTIVE SINCE
Jan 2024
HOLDINGS NOW
22,500
AVG SELL PX
TRADE KIND
SHOWING 4 / 4
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Brian Cogley, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+0.00%-21.63%-0.90%-20.73%-20.73%
14d1+0.00%-19.59%+1.85%-21.45%-21.45%
30d1+0.00%-27.58%+5.17%-32.75%-32.75%
60d1+0.00%-36.72%+7.29%-44.01%-44.01%
90d1+0.00%-43.56%+9.31%-52.87%-52.87%
180d1+0.00%-58.64%+17.26%-75.89%-75.89%
1y1+0.00%-49.27%+25.28%-74.56%-74.56%
2y1+100.00%+3.77%+47.95%-44.18%-44.18%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
COEP · 22,500 shares · as of Feb 11, 2026
07,50015,00022,50030,00020252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 4 buys / 0 sellsCOVERAGE · 9 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
12,50022,500Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Financial Officer
10,000$10.56$105.6K22,500Feb 11, 2026Feb 13, 2026View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASEGRANT
Stock grant
10,00022,500Mar 4, 2025Mar 6, 2025View →
COEP
COEPTIS THERAPEUTICS HOLDINGS, INC.
PURCHASE
Chief Financial Officer
5,000$0.67$3.4K30,000Jan 10, 2024Jan 17, 2024View →
Other insiders · COEP
Loading peer insiders…
About this filer
CIK 0002008384
ROLE
Chief Financial Officer
PRIMARY
COEP
COMPANIES
1
ACTIVE SINCE
Jan 2024
MARKETPEEL · /INSIDER/0002008384DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback